Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

Susvimo is also approved to treat age-related macular degeneration, and the medication, ranibizumab, is delivered though a ...

Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...

Patients with MacTel type 2 often initially present with symptoms in their fifth decade ... vision due to subretinal hemorrhage, cystoid macular edema, hard exudates and disciform scarring ...

Abnormalities of the vitreoretinal interface may contribute to important retinal pathologies such as diabetic retinopathy, diabetic macular edema and ... waiting' until symptoms worsen may not ...

Feb. 6, 2025 — The FDA has approved a new implantable treatment for adults with diabetic macular edema (DME) after studies showed that it could help maintain vision with as few as two ...

Diabetic macular edema can result in low vision or vision loss. Early treatment can help preserve vision longer. Diabetic macular edema (DME) is a complication of diabetes. Over time, high blood ...

Diabetic macular edema occurs when fluid leaks from blood vessels in the retina, causing swelling in the macula that can lead to vision loss in people with diabetes. Let's explore the latest ...